Ban TA. The butyrophenones in psychiatry. In: Lehmann HE, Ban T, eds. The Butyrophenones in Psychiatry. Montreal: Quebec Psychopharmacological Research Association; 1964, p. 127-30.

Ban TA. Trimipramine in psychiatry. In: Lehmann HE, Berthiaume M, Ban TA, eds. Trimipramine A New Anti-Depressant. Montreal; Quebec Psychopharmacological Research Asociation; 1964, p. 95-6.

Ban TA. The history of the Quebec Psychopharmacological Research Association. In: Ban TA, Healy D, Shorter E. Reflections on Twentieth-Century Psychopharmacology. Volume 4 of The History of Psychopharmacology and the CINP, As Told in Autobiography. Budapest: Animula; 2004, p. 621-3.

Ban TA, Lehmann HE. Skin pigmetation, a rare side effect of chlorpromazine. Canadian Psychiatric Association Journal 1965; 10: 112-24.

Ban TA, St.Jean  A. The effect of phenothiazines on the electrocardiogram. Canadian Medical Association Journal 1965; 91: 537- 40. 

Ban TA, Stonehill E. Clinical observations on the differential effects of a butyrophenone (haloperidol) and a phenothiazine (fluphenazine) in chronic schizophrenic patients.  In:  Lehmann HE, Ban T, eds. The Butyrophenones in Psychiatry. Montreal: Quebec Psychopharmacological Research Association; 1964, p. 113-9.

Erutku I, Ban TA, Lehmann HE. The effect of trimipramine in newly admitted depressed patients. In: Lehmann HE, Berthiaume M, Ban TA, eds. Trimipramine A New Anti-Depressant. Montreal; Quebec Psychopharmacological Research Asociation; 1964, p. 59-64.

Lehmann HE, Ban TA. The Butyrophenones in Psychiatry. Montreal: Qeubec Psychopharmacological Research Association; 1964.

Lehmann HE, Ban TA, eds. Toxicity and Adverse Reaction Studies with Psychoactive Drugs. Quebec Psyhopharmacological Research Asociation; 1965.

Lehmann HE,Ban TA, eds. The Thioxanthenes (Modern Problems of Pharmacopsychiatry, Volume 2). Basel: Karger; 1969a

Lehmann HE, Ban TA. Studies with Thioxanthenes. In: Lehmann HE, Ban TA, eds. The Thioxanthenes (Modern Problems of Pharmacopsychiatry, Volume 2). Basel: Karger; 1969b, p. 85-9.   

Lehmann HE, Ban TA, Matthews MB, Garcia-Rill T. The effects of halopriol in acute schizophrenic patients. A comparative study of haloperidol, chlorpromazine and chlorprothixene. In: Lehmann HE, Ban TA, eds. The Butyrophenones in Psychiatry. Montreal: Quebec Psychopharmacological Research Association; 1964, p. 77-88.

Lehmann HE, Berthiaume M, Ban TA, eds. Trimipramine A New Anti-Depressant. Montreal; Quebec Psychopharmacological Research Asociation; 1964.

Lehmann HE, Kral VA, Ban TA, Ast H, Barriga C, Lidsky A. The effects of trimipramine on geriatric patients. In: Lehmann HE, Berthiaume M, Ban TA, eds. Trimipramine A New Anti-Depressant. Montreal; Quebec Psychopharmacological Research Association; 1964, p. 69-76.

St. Jean A, Ban TA, Noe W. The effect of trimipramine on psychophysical test performances. In: Lehmann HE, Berthiaume M, Ban TA, eds. Trimipramine A New Anti-Depressant. Montreal; Quebec Psychopharmacological Research Association; 1964, p. 29-31.

 St.Jean, A, Lidsky A, Ban TA, Lehmann HE. The psychophysical effects of butyrophenones in male schizophrenics. In: Lehmann HE, Ban T, eds. The Butyrophenones in Pschiatry.  Montreal: Quebec Psychopharmacological Research Association; 1964, p. 38-52.

Warnes H, Lee H, Ban TA. The comparative effectiveness of butyrophenones in chronic psychotic patients. In: Lehmann HE, Ban T, eds. The Butyrophenones in Psychiatry. Montreal: Quebec Psychopharmacological Research Association; 1964, p. 100-12.